Tracy is a Programme Coordinator with the Department of Clinical Sciences, supporting the IMPROVE and IMPROVE-2 programmes funded by EDCTP2 and the Joint Global Health Trials (10.5 million Euros). Working with institutions across Africa and Europe Tracy supports Feiko Ter Kuile and Jenny Hill, coordinating the contractual, financial and administrative needs of the programmes, ensuring clear and accurate communications both within research consortia and with funders.
Tracy Seddon was employed by LSTM in 2009 as a Programme Administrator for several European funded programmes worth an estimated 25 million Euro’s. From 2012 to 2014 Tracy supported Professor Imelda Bates to build the Capacity Research Unit which advocates Capacity Strengthening activities in hospitals, laboratories and research institutions across Africa. In 2014 Tracy moved to the Department of Clinical Sciences working with the Respiratory Research Unit. With support from Professor Stephen Gordon, Tracy was responsible for assisting the development and growth of the Experimental Human Pneumococcal Challenge (EHPC) Team supporting activities fundamental to clinical science.
Current Projects:
- IPTp with dihydroartemisinin-piperaquine and azithromycin for malaria, sexually transmitted and reproductive tract infections in pregnancy in high sulphadoxine-pyrimethamine resistance areas in Kenya, Malawi, and Tanzania. TRIA-2015-1076-IMPROVE (Dec 2016 – Nov 2020) €7,300,000 Donor: 2nd European & Developing Countries Clinical Trials Partnership Programme – EDCTP2
- IPTp with dihydroartemisinin-piperaquine and azithromycin for malaria, sexually transmitted and reproductive tract infections in HIV-infected pregnant women in Kenya and Malawi: a multi-centre 3-arm placebo-controlled trial. TRIA-2015-1076b-IMPROVE2 (Jul 2017 – Nov 2020) €3,200,000 Donor: 2nd European & Developing Countries Clinical Trials Partnership Programme – EDCTP2
- Health Utilisation Study - Kenya (Jan 2018 – Dec 2021) $1,215,745 Donor: PATH
- Maximising the public health impact of interventions to control Malaria in pregnancy through the translation of EDCTP funded evidence-based global policies to country level policies and plans – IMMPACT. CSA-2015-IMPPACT (Jan 2016 – Dec 2018). €487,763 Donor: 2nd European & Developing Countries Clinical Trials Partnership Programme – EDCTP2
- Worldwide Antimalarial Drug Resistance network Project, Sub-Study. $536,403 Donor: Bill and Melinda Gates Foundation